Cognition Therapeutics (CGTX) Earnings Date & Reports

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGTX is expected to report earnings to rise 5.00% to -5 cents per share on August 11

Cognition Therapeutics CGTX Stock Earnings Reports

Q2'26

Est.

$-0.05

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.04

Q2'25

Est.

$-0.11

The last earnings report on May 08 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 790.23K shares outstanding, the current market capitalization sits at 150.36M.

View a ticker or compare two or three

Compare

CGTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CGTX